PSIL
PSIL
About AdvisorShares Psychedelics ETF
The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from or devote 50% of their assets to psychedelic drugs and derivatives that have economic characteristics similar to such...
About AdvisorShares Psychedelics ETF
The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from or devote 50% of their assets to psychedelic drugs and derivatives that have economic characteristics similar to such...
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 CMPS | COMPASS Pathways plc | 12.84% | 334.08K | $4.74M |
 ATAI | Atai Beckley Inc. | 10.63% | 814.50K | $3.93M |
 DFTX | Definium Therapeutics, Inc. | 8.54% | 131.08K | $3.15M |
 NRXP | NRx Pharmaceuticals, Inc. | 7.91% | 632.09K | $2.92M |
 RLMD | Relmada Therapeutics, Inc. | 7.38% | 397.95K | $2.73M |
 GHRS | GH Research PLC | 6.30% | 93.72K | $2.33M |
 NBIX | Neurocrine Biosciences, Inc. | 4.80% | 11.01K | $1.77M |
 ALKS | Alkermes plc | 4.53% | 39.60K | $1.67M |
 DRUG | Bright Minds Biosciences Inc. | 4.25% | 19.38K | $1.57M |
 HELP | Cybin Inc. Common Stock | 3.70% | 291.07K | $1.37M |
 ABBV | AbbVie Inc. | 3.61% | 6.25K | $1.33M |
 ANRO | Alto Neuroscience, Inc. | 3.39% | 63.20K | $1.25M |
 NEUP | Neuphoria Therapeutics Inc. | 3.29% | 229.32K | $1.22M |
 JNJ | Johnson & Johnson | 3.24% | 5.35K | $1.20M |
 SUPN | Supernus Pharmaceuticals, Inc. | 3.04% | 25.06K | $1.12M |
 STIM | Neuronetics, Inc. | 2.96% | 653.50K | $1.09M |
 QNTM | Quantum BioPharma Ltd. | 2.34% | 164.59K | $864.12K |
 KTTA | Pasithea Therapeutics Corp. | 1.55% | 800.05K | $572.03K |
 PBM | Psyence Biomedical Ltd. | 1.14% | 100.81K | $422.39K |
| OPTH | Optimi Health Corp. | 0.97% | 63.20K | $356.47K |
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States
Canada
United Kingdom
Ireland
AustraliaSECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States Canada United Kingdom Ireland AustraliaHoldings (Top 20)
CMPS
COMPASS Pathways plc
ATAI
Atai Beckley Inc.
DFTX
Definium Therapeutics, Inc.
NRXP
NRx Pharmaceuticals, Inc.
RLMD
Relmada Therapeutics, Inc.
GHRS
GH Research PLC
NBIX
Neurocrine Biosciences, Inc.
ALKS
Alkermes plc
DRUG
Bright Minds Biosciences Inc.
HELP
Cybin Inc. Common Stock
ABBV
AbbVie Inc.
ANRO
Alto Neuroscience, Inc.
NEUP
Neuphoria Therapeutics Inc.
JNJ
Johnson & Johnson
SUPN
Supernus Pharmaceuticals, Inc.
STIM
Neuronetics, Inc.
QNTM
Quantum BioPharma Ltd.
KTTA
Pasithea Therapeutics Corp.
PBM
Psyence Biomedical Ltd.
OPTH
Optimi Health Corp.